Open-Angle Glaucoma (OAG) Market Size Forecasted To Achieve 8.42 Billion By 2029 With Steady Growth

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Open-Angle Glaucoma (OAG) Market Size and Projected Growth Rate?
The market size for open-angle glaucoma (OAG) has experienced robust growth in the past few years. This growth is projected to continue, increasing from $6.13 billion in 2024 to a projected $6.55 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. The growth during the historical period is primarily a result of a higher incidence rate of glaucoma in older populations, increased awareness of the importance of early detection of eye conditions, a rise in healthcare spending, government efforts towards vision care schemes, and the broadening of ophthalmology practices around the world.

In the ensuing years, the market size for open-angle glaucoma (OAG) is anticipated to register considerable growth, escalating to $8.42 billion in 2029 with a compound annual growth rate (CAGR) of 6.5%. Factors attributing to this forecasted growth include rising demand for combination treatments, an enhanced focus on personalized healthcare, more efficient reimbursement strategies for glaucoma procedures, an increase in lifestyle-related eye conditions, and a growing preference for non-invasive diagnostic techniques. Key trends for this period include the increased implementation of Artificial Intelligence in glaucoma diagnosis, a transition towards outpatient glaucoma surgical procedures, the growing usage of sustained-release glaucoma implants, the surge in integration of wearable technology for monitoring intraocular pressure, and an increased emphasis on sustainability in the manufacturing of medical devices.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911

What Are the Major Segments in the Open-Angle Glaucoma (OAG) Market?
The open-angle glaucoma (OAG) market covered in this report is segmented -

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type
2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma
3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Are The Driving Open-Angle Glaucoma (OAG) Market Evolution?
The increased understanding of eye diseases is set to stimulate the expansion of the open-angle glaucoma (OAG) market. Eye ailments include health conditions that affect either the structure, function, or vision quality of the eyes, varying from minor issues like dry eye to severe diseases such as glaucoma and macular degeneration. The increase in their occurrence is attributable to older populations, long-term screen use, a growing occurrence of diabetes, environamental pollution, and lifestyle practices which burden eye health. Open-angle glaucoma (OAG) being a prime reason for blindness particularly in the elderly, emphasizes the urgent necessity for regular eye check-ups, early detection, and preemptive treatments as a guard against unrecoverable vision impairment. For example, the Royal National Institute of Blind People (RNIB), a UK-based charity for sight loss, stated that in October 2023, eye care outpatient appointments in the UK surpassed eight million in 2021/22, registering it as the top largely sought-after specialty. Moreover, the count of individuals suffering from vision loss, currently more than two million, is predicted to reach over four million by 2050. Hence, the escalating knowledge of eye diseases is contributing towards the growth of the open-angle glaucoma (OAG) market.

Which Firms Dominate The Open-Angle Glaucoma (OAG) Market Segments?
Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals

What Trends Are Expected to Dominate the Acquired Autoimmune Hemolytic Anemia Market in the Next 5 Years?
Leading firms in the open-angle glaucoma (OAG) market, are focusing on creating progressive solutions, such as minimally invasive glaucoma devices (MIGDs), to offer less invasive methods to manage primary open-angle glaucoma and decrease dependence on conventional treatments. A MIGD is a range of surgical instruments and procedures aimed at decreasing eye pressure in glaucoma patients through minor incisions with little disruption to the eye tissues. For example, in December 2023, the Belgium-based medical technology firm, iSTAR Medical, introduced MINIject in the Netherlands. This new approach for primary open-angle glaucoma uses a unique porous STAR material to boost the outflow of fluid and decrease intraocular pressure (IOP). By reducing reliance on traditional therapies, MINIject marks a significant advancement in glaucoma treatment, providing a safer and more effective management alternative for this main cause of irreversible blindness.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Is The Largest Region In The Open-Angle Glaucoma (OAG) Market?
North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Open-Angle Glaucoma (OAG) Market?
2. What is the CAGR expected in the Open-Angle Glaucoma (OAG) Market?
3. What Are the Key Innovations Transforming the Open-Angle Glaucoma (OAG) Industry?
4. Which Region Is Leading the Open-Angle Glaucoma (OAG) Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.